Peter van Luijk
Overview
Explore the profile of Peter van Luijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Vette S, van Rijn-Dekker M, Van den Bosch L, Keijzer K, Neh H, Chu H, et al.
Oral Oncol
. 2025 Mar;
163:107224.
PMID: 40023984
Background/purpose: Normal tissue complication probability (NTCP) models can be used to guide radiation therapy (RT) decisions by estimating side-effect risks pretreatment to minimize (late) side-effects. Recently, a comprehensive individual toxicity...
2.
Frederiks M, van Etten B, Kelder W, Dieters M, Beukema J, IJsbrandy C, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39800330
Purpose: Neoadjuvant chemoradiation therapy (RT) (nCRT) followed by surgical resection is the current standard of care for patients with esophageal cancer (EC). This treatment is associated with a variety of...
3.
van Rijn-Dekker M, van der Schaaf A, Nienhuis S, Arents-Huls A, Ger R, Hamming-Vrieze O, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766181
Background/objectives: Studies have shown that dose to the parotid gland stem cell rich (SCR) regions should be reduced to lower the risk of xerostomia after radiotherapy (RT). This study aimed...
4.
Hessels A, Frederiks M, Muijs C, van Luijk P
JTO Clin Res Rep
. 2024 Oct;
5(11):100718.
PMID: 39399796
No abstract available.
5.
Beukema J, Haveman J, Langendijk J, Oldehinkel E, van den Bergh A, de Haan J, et al.
Radiother Oncol
. 2024 Aug;
200:110479.
PMID: 39154840
Purpose: The aim of this study was to test the hypothesis that the levels of High Sensitive Troponin T (HS-TNT) and N-terminal Brain Natriuretic Peptide (NT-ProBNP) increase after radiation therapy...
6.
Wiedemann J, Paruchuru S, den Boef L, Brouwer U, Sillje H, Schouten E, et al.
Int J Radiat Oncol Biol Phys
. 2024 Aug;
121(1):191-201.
PMID: 39151832
Purpose: When irradiating thoracic tumors, dose to the heart or lung has been associated with survival. We previously showed in a rat model that in addition to known side effects...
7.
van Rijn-Dekker M, la Bastide-van Gemert S, Stokman M, Vissink A, Coppes R, Langendijk J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(3):772-782.
PMID: 38631537
Purpose: Previous studies have shown that the mean dose to the parotid gland stem cell rich regions (D) is the strongest dosimetric predictor for the risk of patient-reported daytime xerostomia....
8.
Voshart D, Klaver M, Jiang Y, van Weering H, van Buuren-Broek F, van der Linden G, et al.
Radiother Oncol
. 2024 Mar;
193:110117.
PMID: 38453539
Background And Purpose: Although proton therapy is increasingly being used in the treatment of paediatric and adult brain tumours, there are still uncertainties surrounding the biological effect of protons on...
9.
van Rijn-Dekker M, van Luijk P, Schuit E, van der Schaaf A, Langendijk J, Steenbakkers R
Int J Radiat Oncol Biol Phys
. 2023 May;
117(3):750-762.
PMID: 37150262
Purpose: Despite improvements to treatment, patients with head and neck cancer (HNC) still experience radiation-induced xerostomia due to salivary gland damage. The stem cells of the parotid gland (PG), concentrated...
10.
Olch A, van Luijk P, Hua C, Avanzo M, Howell R, Yorke E, et al.
Int J Radiat Oncol Biol Phys
. 2023 Apr;
119(2):360-368.
PMID: 37003845
Purpose: We describe the methods used to estimate the accuracy of dosimetric data found in literature sources used to construct the Pediatric Normal Tissue Effects in the Clinic (PENTEC) dose-response...